Bone graft substitutes: What are the options?

Surgeon

Volumn 10, Issue 4, 2012, Pages 230-239

  Dinopoulos, Haralambos ^a   Dimitriou, Rozalia ^a   Giannoudis, Peter V ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Bone grafts; Bone substitutes; Bone void fillers; Osteobiologics

Indexed keywords

BONE DISEASE; BONE PROSTHESIS; BONE REGENERATION; BONE TRANSPLANTATION; HUMAN; METHODOLOGY; REVIEW;

BONE DISEASES; BONE REGENERATION; BONE SUBSTITUTES; BONE TRANSPLANTATION; HUMANS;

EID: 84864094689     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surge.2012.04.001     Document Type: Review

References (93)

1. De Long W.G., Einhorn T.A., Koval K., McKee M., Smith W., Sanders R., et al. Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. J Bone Jt Surg Am 2007, 89(3):649-658.
2. Finkemeier C.G. Bone-grafting and bone-graft substitutes. J Bone Jt Surg Am 2002, 84(3):454-464.
3. Ahlmann E., Patzakis M., Roidis N., Shepherd L., Holtom P. Comparison of anterior and posterior iliac crest bone graft in terms of harvest-site morbidity and functional outcomes. J Bone Jt Surg Am 2002, 84(5):716-720.
4. St John T.A., Vaccaro A.R., Sah A.P., Schaefer M., Berta S.C., Albert T., et al. Physical and monetary costs associated with autogenous bone graft harvesting. Am J Orthop 2003, 32(1):18-23.
5. Greenwald A.S., Boden S.D., Goldberg V.M., Khan Y., Laurencin C.T., Rosier R.N., American Academy of Orthopaedic Surgeons The committee on biological implants. Bone-graft substitutes: facts, fictions, and applications. Bone Jt Surg Am 2001, 83(Suppl. 2 Pt 2):98-103.
6. Jahangir A.A., Nunley R.M., Mehta S., Sharan A., the Washington Health Policy Fellows Bone-graft substitutes in orthopaedic surgery. AAOS Now 2008 January, http://www.aaos.org/news/aaosnow/jan08/reimbursement2.asp.
7. Desai B.M. Osteobiologics. Am J Orthop (Belle Mead NJ) 2007, 36(4 Suppl.):8-11.
8. Giannoudis P.V., Dinopoulos H., Tsiridis E. Bone substitutes: an update. Injury 2005, 36:S20-S27.
9. Einhorn T.A. Enhancement of fracture healing. J Bone Jt Surg Am 1995, 77:940-956.
10. Dimitriou R., Tsiridis E., Giannoudis P.V. Current concepts of molecular aspects of bone healing. Injury 2005, 36(12):1392-1404.
11. Keramaris N.C., Calori G.M., Nikolaou V.S., Schemitsch E.H., Giannoudis P.V. Fracture vascularity and bone healing: a systematic review of the role of VEGF. Injury 2008 Sep, 39(Suppl. 2):S45-S57.
12. Bielby R., Jones E., McGonagle D. The role of mesenchymal stem cells in maintenance and repair of bone. Injury 2007 Mar, 38(Suppl. 1):S26-S32.
13. Laurencin C., Khan Y., El-Amin S.F. Bone graft substitutes. Expert Rev Med Devices 2006, 3(1):49-57.
14. Bauer T.W., Muschler G.F. Bone graft materials: an overview of the basic science. Clin Orthop Relat Res 2000, 371:10-27.
15. Khan S.N., Cammisa F.P., Sandhu H.S., Diwan A.D., Girardi F.P., Lane J.M. The biology of bone grafting. J Am Acad Orthop Surg 2005, 13:77-86.
16. Sen M.K., Miclau T. Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions?. Injury 2007, 38(Suppl. 1):S75-S80.
17. Horne L.T., Murray P.M., Saha S., Sidhar K. Effects of distal radius bone graft harvest on the axial compressive strength of the radius. J Hand Surg Am 2010, 35(2):262-266.
18. Krause J.O., Perry C.R. Distal femur as a donor site of autogenous cancellous bone graft. J Orthop Trauma 1995, 9(2):145-151.
19. Mazock J.B., Schow S.R., Triplett R.G. Proximal tibia bone harvest: review of technique, complications, and use in maxillofacial surgery. Int J Oral Maxillofac Implants 2004, 19(4):586-593.
20. Raikin S.M., Brislin K. Local bone graft harvested from the distal tibia or calcaneus for surgery of the foot and ankle. Foot Ankle Int 2005, 26(6):449-453.
21. Cox G., Jones E., McGonagle D., Giannoudis P.V. Reamer-irrigator-aspirator indications and clinical results: a systematic review. Int Orthop 2011, [Epub ahead of print].
22. Dell P.C., Burchardt H., Glowczewskie F.P. A roentgenographic, biomechanical, and histological evaluation of vascularized and non-vascularized segmental fibular canine autografts. J Bone Jt Surg Am 1985, 67(1):105-112.
23. Connolly J.F. Injectable bone marrow preparations to stimulate osteogenic repair. Clin Orthop Relat Res 1995, 313:8-18.
24. Curylo L.J., Johnstone B., Petersilge C.A., Janicki J.A., Yoo J.U. Augmentation of spinal arthrodesis with autologous bone marrow in a rabbit po-sterolateral spine fusion model. Spine 1999, 24:434-438.
25. Pountos I., Georgouli T., Kontakis G., Giannoudis P.V. Efficacy of minimally invasive techniques for enhancement of fracture healing: evidence today. Int Orthop 2010, 34(1):3-12.
26. Hernigou P., Poignard A., Beaujean F., Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Jt Surg Am 2005, 87(7):1430-1437.
27. Jäger M., Herten M., Fochtmann U., Fischer J., Hernigou P., Zilkens C., et al. Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects. J Orthop Res 2011, 29(2):173-180.
28. Tiedeman J.J., Garvin K.L., Kile T.A., Connolly J.F. The role of a composite, DBM and bone marrow in the treatment of osseous defects. Orthopedics 1995, 18:1153-1158.
29. D'Ippolito G., Schiller P.C., Ricordi C., Roos B.A., Howard G.A. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999, 14(7):1115-1122.
30. Huibregtse B.A., Johnstone B., Goldberg V.M., Caplan A.I. Effect of age and sampling site on the chondro-osteogenic potential of rabbit marrow-derived mesenchymal progenitor cells. J Orthop Res 2000, 18(1):18-24.
31. Farrington M., Matthews I., Foreman J., Richardson K.M., Caffrey E. Microbiological monitoring of bone grafts: two years' experience at a tissue bank. J Hosp Infect 1998, 38:261-271.
32. Kappe T., Cakir B., Mattes T., Reichel H., Flören M. Infections after bone allograft surgery: a prospective study by a hospital bone bank using frozen femoral heads from living donors. Cell Tissue Bank 2010 Aug, 11(3):253-259.
33. Mankin H.J., Hornicek F.J., Raskin K.A. Infection in massive bone allografts. Clin Orthop Relat Res 2005, 432:210-216.
34. Buck B.E., Malinin T.I., Brown M.D. Bone transplantation and human immunodeficiency virus. An estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin Orthop Relat Res 1989 Mar, 240:129-136.
35. Centers for Disease Control and Prevention Hepatitis C virus transmission from an antibody-negative organ and tissue donor, United States, 2000-2002. Morb Mortal Wkly Rep 2003, 52:273-276.
36. Katz J.M., Nataraj C., Jaw R., Deigl E., Bursac P. Demineralized bone matrix as an osteoinductive biomaterial and in vitro predictors of its biological potential. J Biomed Mater Res B Appl Biomater 2009, 89:127-134.
37. Peterson B., Whang P.G., Iglesias R., Wang J.C., Lieberman J.R. Osteoinductivity of commercially available demineralized bone matrix. Preparations in a spine fusion model. J Bone Jt Surg Am 2004, 86:2243-2250.
38. Wang J.C., Alanay A., Mark D., Kanim L.E.A., Campbell P.A., Dawson E.G., et al. A comparison of commercially available demineralized bone matrix for spinal fusion. Eur Spine J 2007, 16:1233-1240.
39. Docquier P.L., Delloye C. Treatment of aneurysmal bone cysts by introduction of demineralized bone and autogenous bone marrow. J Bone Jt Surg Am 2005, 87:2253-2258.
40. Tynan J.R., Schachar N.S., Marshall G.B., Gray R.R. Pathologic fracture through a unicameral bone cyst of the pelvis: CT- guided percutaneous curettage, biopsy, and bone matrix injection. J Vasc Interv Radiol 2005, 16:293-296.
41. Dinopoulos H.T., Giannoudis P.V. Safety and efficacy of use of demineralised bone matrix in orthopaedic and trauma surgery. Expert Opin Drug Saf 2006 Nov, 5(6):847-866.
42. Urist M.R. Bone: formation by autoinduction. Science 1965, 150(698):893-899.
43. Giannoudis P.V., Einhorn T.A. Bone morphogenetic proteins in musculoskeletal medicine. Injury 2009, 40(Suppl. 3):S1-S3.
44. Nauth A., Giannoudis P.V., Einhorn T.A., Hankenson K.D., Friedlaender G.E., Li R., et al. Growth factors: beyond bone morphogenetic proteins. J Orthop Trauma 2010, 24(9):543-546.
45. Simpson A.H., Mills L., Noble B. The role of growth factors and related agents in accelerating fracture healing. J Bone Jt Surg Br 2006, 88(6):701-705.
46. Dallari D., Savarino L., Stagni C., Cenni E., Cenacchi A., Fornasari P.M., et al. Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. J Bone Jt Surg Am 2007, 89:2413-2420.
47. Tang C.H., Yang R.S., Huang T.H., Liu S.H., Fu W.M. Enhancement of fibronectin fibrillogenesis and bone formation by basic fibroblast growth factor via protein kinase c-dependent pathway in rat osteoblasts. Mol Pharmacol 2004, 66:440-449.
48. Geiger F., Lorenz H., Xu W., Szalay K., Kasten P., Claes L., et al. VEGF producing bone marrow stromal cells (BMSC) enhance vascularization and resorption of a natural coral bone substitute. Bone 2007, 41:516-522.
49. Argintar E., Edwards S., Delahay J. Bone morphogenetic proteins in orthopaedic trauma surgery. Injury 2011 Aug, 42(8):730-734.
50. Blokhuis T.J. Formulations and delivery vehicles for bone morphogenetic proteins: latest advances and future directions. Injury 2009, 40(Suppl. 3):S8-11.
51. Alsousou J., Thompson M., Hulley P., Noble A., Willett K. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Jt Surg Br 2009, 91(8):987-996.
52. Lowery G.L., Kulkarni S., Pennisi A.E. Use of autologous growth factors in lumbar spinal fusion. Bone 1999, 25(2 Suppl.):47-50.
53. Jenis L.G., Banco R.J., Kwon B. A prospective study of Autologous Growth Factors (AGF) in lumbar interbody fusion. Spine J 2006, 6(1):14-20.
54. Bi L., Cheng W., Fan H., Pei G. Reconstruction of goat tibial defects using an injectable tricalcium phosphate/chitosan in combination with autologous platelet-rich plasma. Biomaterials 2010, 31:3201-3211.
55. Hartmann E.K., Heintel T., Morrison R.H., Weckbach A. Infiuence of platelet-rich plasma on the anterior fusion in spinal injuries: a qualitative and quantitative analysis using computer tomography. Arch Orthop Trauma Surg 2010, 130:909-914.
56. Cenni E., Avnet S., Fotia C., Salerno M., Baldini N. Platelet-rich plasma impairs osteoclast generation from human precursors of peripheral blood. J Orthop Res 2010, 28:792-797.
57. Forriol F., Longo U.G., Concejo C., Ripalda P., Maffulli N., Denaro V. Platelet-rich plasma, rhOP-1 (rhBMP-7) and frozen rib allograft for the reconstruction of bony mandibular defects in sheep. A pilot experimental study. Injury 2009 Dec, 40(Suppl. 3):S44-S49.
58. McGonagle D., English A., Jones E.A. The relevance of mesenchymal stem cells in vivo for future orthopaedic strategies aimed at fracture repair. Curr Orthop 2007, 21(4):262-267.
59. Robey P.G. Stem cells near the century mark. J Clin Invest 2000, 105:1489-1491.
60. Watt F.M., Hogan B.L. Out of Eden: stem cells and their niches. Science 2000, 287:1427-1430.
61. Papathanasopoulos A., Giannoudis P.V. Biological considerations of mesenchymal stem cells and endothelial progenitor cells. Injury 2008, 39(Suppl. 2):S21-S32.
62. Sempuku T., Ohgushi H., Okumura M., Tamai S. Osteogenic potential of allogeneic rat marrow cells in porous hydroxyapatite ceramics: a histological study. J Orthop Res 2005, 14:907-913.
63. Arinzeh T.L., Peter S.J., Archambault M.P., van den Bos C., Gordon S., Kraus K., et al. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Jt Surg Am 2003, 85:1927-1935.
64. Patterson T.E., Kumagai K., Griffith L., Muschler G.F. Cellular strategies for enhancement of fracture repair. J Bone Jt Surg Am 2008, 90(Suppl. 1):111-119.
65. Cornell C.N. Osteoconductive materials and their role as substitutes for autogenous bone grafts. Orthop Clin North Am 1999, 30(4):591-598.
66. Nandi S.K., Roy S., Mukherjee P., Kundu B., De D.K., Basu D. Orthopaedic applications of bone graft & graft substitutes: a review. Indian J Med Res 2010, 132:15-30.
67. Fleming J.E., Cornell C.N., Muschler G.F. Bone cells and matrices in orthopaedic tissue engineering. Orthop Clin North Am 2000, 31:357-374.
68. Chen Y. Orthopaedic application of gene therapy. J Orthop Sci 2001, 6:199-207.
69. Lind M., Bünger C. Orthopaedic applications of gene therapy. Int Orthop 2005, 29:205-209.
70. Calori G.M., Donati D., Di Bella C., Tagliabue L. Bone morphogenetic proteins and tissue engineering: future directions. Injury 2009, 40(Suppl. 3):S67-S76.
71. Bohner M. Calcium orthophosphates in medicine: from ceramics to calcium phosphate cements. Injury 2000, 31(Suppl. 4):37-47.
72. Hak D.J. The use of osteoconductive bone graft substitutes in orthopaedic trauma. J Am Acad Orthop Surg 2007, 15:525-536.
73. Balçik C., Tokdemir T., Senköylü A., Koç N., Timuçin M., Akin S., et al. Early weight bearing of porous HA/TCP (60/40) ceramics in vivo: a longitudinal study in a segmental bone defect model of rabbit. Acta Biomater 2007, 3:985-996.
74. Ghosh S.K., Nandi S.K., Kundu B., Datta S., De D.K., Roy S.K., et al. In vivo response of porous HA and ß-TCP prepared by aqueous solution combustion method and comparison with bioglass scaffolds. J Biomed Mater Res B Appl Biomater 2008, 86:217-227.
75. Noshi T., Yoshikawa T., Ikeuchi M., Dohi Y., Ohgushi H., Horiuchi K., et al. Enhancement of the in vivo osteogenic potential of marrow/hydroxyapatite composites by bovine bone morphogenetic protein. J Biomed Mater Res 2000, 52(4):621-630.
76. Daculsi G. Biphasic calcium phosphate concept applied to artificial bone, implant coating and injectable bone substitute. Biomaterials 1998, 19(16):1473-1478.
77. Moroni A., Pegreffi F., Cadossi M., Hoang-Kim A., Lio V., Giannini S. Hydroxyapatite-coated external fixation pins. Expert Rev Med Devices 2005, 2:465-471.
78. Nguyen H.Q., Deporter D.A., Pilliar R.M., Valiquette N., Yakubovich R. The effect of sol-gel-formed calcium phosphate coatings on bone ingrowth and osteoconductivity of porous-surfaced Ti alloy implants. Biomaterials 2004, 25:865-876.
79. Kopylov P., Runnqvist K., Jonsson K., Aspenberg P. Norian SRS versus external fixation in redisplaced distal radial fractures. A randomized study in 40 patients. Acta Orthop Scand 1999, 70:1-5.
80. Sanchez-Sotelo J., Munuera L., Madero R. Treatment of fractures of the distal radius with remodellable bone cement: a prospective, randomised study using Norian SRS. J Bone Jt Surg Br 2000, 82:856-863.
81. Gross V., Brandes J. The ultrastructure of the interface between a glass ceramic and bone. J Biomed Mater Res 1981, 15:291-305.
82. Kinnunen I., Aitasalo K., Pollonen M., Varpula M. Reconstruction of orbital fioor fractures using bioactive glass. J Craniomaxillofac Surg 2000, 28:22-34.
83. Peltola M., Suonpaa J., Aitasalo K., Määttänen H., Andersson O., Yli-Urpo A., et al. Experimental follow-up model for clinical frontal sinus obliteration with bioactive glass. Acta Otolaryngol Suppl 2000, 543:167-169.
84. Cao W., Hench L.L. Bioactive materials. Ceramics Int 1996, 22:493-507.
85. Peters C.L., Hines J.L., Bachus K.N., Craig M.A., Bloebaum R.D. Biological effects of calcium sulphate as a bone graft substitute in ovine metaphyseal defects. J Biomed Mater Res A 2006, 76:456-462.
86. Maeda S.T., Bramane C.M., Taga R., Garcia R.B., de Moraes I.G., Bernadineli N. Evaluation of surgical cavities filled with three types of calcium sulphate. J Appl Oral Sci 2007, 15:416-419.
87. Mirzayan R., Panossian V., Avedian R., Forrester D.M., Menendez L.R. The use of calcium sulphate in the treatment of benign bone lesions. A preliminary report. J Bone Jt Surg Am 2001, 83:355-358.
88. Chiroff R.T., White E.W., Weber K.N., Roy D.M. Tissue ingrowth of replamineform implants. J Biomed Mater Res 1975, 9:29-45.
89. Coughlin M.J., Grimes J.S., Kennedy M.P. Coralline hydroxyapatite bone graft substitute in hindfoot surgery. Foot Ankle Int 2006, 27(1):19-22.
90. Giannoudis P.V., Einhorn T.A., Marsh D. Fracture healing: the diamond concept. Injury 2007, 38(Suppl. 4):S3-S6.
91. Dimitriou R., Jones E., McGonagle D., Giannoudis P.V. Bone regeneration: current concepts and future directions. BMC Med 2011 May 31, 9:66.
92. Brydone A.S., Meek D., Maclaine S. Bone grafting, orthopaedic biomaterials, and the clinical need for bone engineering. Proc Inst Mech Eng H 2010 Dec, 224(12):1329-1343.
93. Aloy-Prósper A., Maestre-Ferrin L., Peñarrocha-Oltra D., Peñarrocha-Diago M. Bone regeneration using particulate grafts: an update. Med Oral Patol Oral Cir Bucal 2011 Mar 1, 16(2). e210-4.